Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 99.45
+0.15 (0.15%)
Aug 22, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 170.33 billion as of August 22, 2025. Its market cap has increased by 170.14% in one year.
Market Cap
170.33B
Enterprise Value
164.96B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
99.45
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 170.33B, an increase of 818.78%. That is a compound annual growth rate of 38.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 170.33B | 184.09% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | 115.10B | 243.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.89B |
| Hansoh Pharmaceutical Group Company | 213.81B |
| JD Health International | 203.69B |
| Akeso | 145.95B |
| Sino Biopharmaceutical | 133.42B |
| WuXi Biologics | 124.64B |
| CSPC Pharmaceutical Group | 118.33B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.50B |